| Investigator | Title | Sponsor | ID | Dates | Amount | 
        
            | Jamie K Capal, MD | Secondary Analyses: The Effects of Epileptogenesis on ASD Clinical Phenotypes | Massachusetts General Hospital (Health Resources & Services Admin) | 226859 | 9/1/2017 - 8/31/2018 | $15,000 | 
        
            | Donald L Gilbert, MD | GABAergic Sensorimotor Dysfunction in Tourette Syndrome | Kennedy Krieger Research Institute (National Institutes of Health (NIH)) | 113091-0319 | 4/1/2018 - 3/31/2019 | $189,960 | 
        
            | Donald L Gilbert, MD | Is Procedural Memory Enhanced in Tourette Syndrome? | Georgetown University Medical Center (Tourette Association of America) | 412681_GR412622_CCHM | 10/1/2018 - 9/30/2019 | $10,093 | 
        
            | Donald L Gilbert, MD | Collaborative Genomic Studies of Tourette Disorder | National Institutes of Health (NIH) | 1R01MH115962-01 | 4/1/2019 - 3/31/2020 | $238,500 | 
        
            | Tracy A Glauser, MD | Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT) | University of Cincinnati (National Institutes of Health (NIH)) | 011609-002 | 7/1/2018 - 6/30/2019 | $159,000 | 
        
            | Christina Gross, PHD | MicroRNA-mediated silencing of the Kv4.2 complex in epilepsy | National Institutes of Health (NIH) | R01NS092705 | 1/1/2019 - 12/31/2019 | $341,250 | 
        
            | Christina Gross, PHD | Mechanism-based treatment targets and biomarkers for genetically defined mental illnesses | Brain & Behavior Research Foundation | 25746 | 9/15/2018 - 9/14/2019 | $50,000 | 
        
            | Christina Gross, PHD | Mechanism-targeted treatment strategy in PTEN-associated autism and epilepsy | National Institutes of Health (NIH) | 1R21HD093033-01A1 | 6/1/2019 - 5/31/2020 | $402,048 | 
        
            | Christina Gross, PHD | FMR1 Gene Therapy for Fragile X Syndrome | FRAXA Research Foundation | FRAXA_Gross | 5/1/2019 - 4/30/2020 | $45,000 | 
        
            | Andrew D Hershey, MDPHD | Pediatric Migraine Registry Duke Univ/FDA | Duke University (Food and Drug Administration) | 234691/240919 | 12/4/2018 - 8/31/2019 | $5,989 | 
        
            | Darren Kadis, PHD | MEG Connectivity-Based Mapping of Critical Language Site | National Institutes of Health (NIH) | R21NS106631 | 9/15/2018 - 8/31/2019 | $223,615 | 
        
            | Darcy Krueger, MD | Early biomarkers of Autism Spectrum Disorders in infants | Children's Hospital Boston (National Institutes of Health (NIH)) | GENFD0001563311 | 9/1/2017 - 8/31/2019 | $55,434 | 
        
            | Darcy Krueger, MD | Early biomarkers of Autism Spectrum Disorders in infants | Children's Hospital Boston (National Institutes of Health (NIH)) | GENFD0001563295 | 9/1/2016 - 8/31/2019 | $6,949 | 
        
            | Darcy Krueger, MD | Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations | Children's Hospital Boston (National Institutes of Health (NIH)) | GENFD0001329656 | 8/1/2018 - 7/31/2019 | $79,259 | 
        
            | Darcy Krueger, MD | Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis Comples | University of Alabama-Birmingham (National Institutes of Health (NIH)) | 000510297-001 | 6/1/2018 - 5/31/2019 | $196,359 | 
        
            | Matthew R Skelton, PHD | Identifying critical periods for creatine in brain development | Association for Creatine Deficiencies | CARE001 | 8/1/2018 - 7/31/2019 | $5,000 | 
        
            | John Michael Taylor | The Vascular Effects of Infection in Pediatric Stroke (VIPS II) Study | The Univ of California, San Francisco (National Institutes of Health (NIH)) | 11258sc | 3/31/2019 - 6/30/2019 | $11,766 | 
        
            | Cameron W Thomas, MD | Continued Anticonvulsants after Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study | University of Michigan (Patient-Centered Outcome Research Inst.) | SUBK00007861 | 7/1/2017 - 6/30/2020 | $1,600 | 
        
            | Cameron W Thomas, MD | Spasm Prediction after Symptomatic Neonatal Seizures - the SPASM study | University of Michigan (Pediatric Epilepsy Research Fdn) | 3005082503 | 9/1/2017 - 8/31/2019 | $9,000 | 
        
            | Cuixia Tian, MD | MDA Care Center Grant | Muscular Dystrophy Association | 492633 | 1/1/2019 - 12/31/2019 | $50,000 | 
        
            | Cuixia Tian, MD | PPMD Grant Award 2019 for Cincinnati Children's Certified Duchenne Care Center | Parent Project Muscular Dystrophy | Tian_PPMD | 1/1/2019 - 12/31/2019 | $10,000 | 
        
            | Lubov Timchenko, PHD | GSK3 Beta Study in Patients with Myotonic Dystrophy 1 | National Institutes of Health (NIH) | R01AR073379 | 1/15/2019 - 12/31/2019 | $447,079 | 
        
            | Jennifer J Vannest, PHD | A Preliminary Study of the Neurobiology of AAC-Induced Language Recovery in Post-Stroke Aphasia | University of Cincinnati (National Institutes of Health (NIH)) | 011760-003 | 9/1/2018 - 8/31/2019 | $187,902 | 
        
            | Jennifer J Vannest, PHD | Multimodal Neuroimaging Distinguishes Developmental and Disordered Phenotypes in Speech Sound Disorders | National Institutes of Health (NIH) | R21DC017393 | 4/1/2019 - 3/31/2020 | $251,047 | 
        
            | Charles V Vorhees, PHD | LPHN3: Function and Role in ADHD | The Local Initiative for Excellence Fdtn | LIFE_Vorhees | 9/18/2018 - 9/17/2019 | $50,000 | 
        
            | Steve Wu, MD | Cortical Neurophysiologic Biomarkers Related to Response Inhibition in Tourette Syndrome | Tourette Association of America | TSA_Wu | 12/11/2018 - 12/10/2019 | $75,000 | 
        
            | Jing Xiang, MD-PHD | Neuromagnetic High Frequency Oscillations to Guide Epilepsy Surgery | National Institutes of Health (NIH) | R21NS104459 | 8/1/2018 - 7/31/2019 | $221,189 | 
        
            | Current Year Direct | $3,338,039 |